Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2017 Aug 23;7(8):e017173.
doi: 10.1136/bmjopen-2017-017173.

Prevalence of depression and depressive symptoms among outpatients: a systematic review and meta-analysis

Affiliations
Meta-Analysis

Prevalence of depression and depressive symptoms among outpatients: a systematic review and meta-analysis

Jinghui Wang et al. BMJ Open. .

Abstract

Objectives: Depression and depressive symptoms are common mental disorders that have a considerable effect on patients' health-related quality of life and satisfaction with medical care, but the prevalence of these conditions varies substantially between published studies. The aim of this study is to conduct a systematic review and meta-analysis to provide a precise estimate of the prevalence of depression or depressive symptoms among outpatients in different clinical specialties.

Design: Systematic review and meta-analysis.

Data sources and eligibility criteria: The PubMed and PsycINFO, EMBASE and Cochrane Library databases were searched to identify observational studies that contained information on the prevalence of depression and depressive symptoms in outpatients. All studies included were published before January 2016. Data characteristics were extracted independently by two investigators. The point prevalence of depression or depressive symptoms was measured using validated self-report questionnaires or structured interviews. Assessments were pooled using a random-effects model. Differences in study-level characteristics were estimated by meta-regression analysis. Heterogeneity was assessed using standard χ2 tests and the I2 statistic. The study protocol has been registered with PROSPERO under number CRD42017054738.

Results: Eighty-three cross-sectional studies involving 41 344 individuals were included in this study. The overall pooled prevalence of depression or depressive symptoms was 27.0% (10 943/41 344 individuals; 95% CI 24.0% to 29.0%), with significant heterogeneity between studies (p<0.0001, τ2=0.3742, I2=96.7%). Notably, a significantly higher prevalence of depression and depressive symptoms was observed in outpatients than in the healthy controls (OR 3.16, 95% CI 2.66 to 3.76, I2=72.0%, χ 2 =25.33). The highest depression/depressive symptom prevalence estimates occurred in studies of outpatients from otolaryngology clinics (53.0%), followed by dermatology clinics (39.0%) and neurology clinics (35.0%). Subgroup analyses showed that the prevalence of depression and depressive symptoms in different specialties varied from 17.0% to 53.0%. The prevalence of depression and depressive symptoms was higher among outpatients in developing countries than in outpatients from developed countries. Moreover, the prevalence of depression and depressive symptoms in outpatients slightly decreased from 1996 to 2010. Regarding screening instruments, the Beck Depression Inventory led to a higher estimate of the prevalence of depression and depressive symptoms (1316/4702, 36.0%, 95% CI 29.0% to 44.0%, I2=94.8%) than the Hospital Anxiety and Depression Scale (1003/2025, 22.0%, 95% CI 12.0% to 35.0%, I2=96.6%).

Conclusion: Our study provides evidence that a significant proportion of outpatients experience depression or depressive symptoms, highlighting the importance of developing effective management strategies for the early identification and treatment of these conditions among outpatients in clinical practice. The substantial heterogeneity between studies was not fully explained by the variables examined.

Keywords: mental health; meta-analysis.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Flow diagram of study inclusion.
Figure 2
Figure 2
Forest plot of the prevalence of depression or depressive symptoms among outpatients. E.N.T., ear, nose, throat.
Figure 3
Figure 3
Bar graph of meta-analysis of the prevalence of depression or depressive symptoms among outpatients stratified by age and study year. (A) Prevalence of depression or depressive symptoms among outpatients stratified by year of study publication. (B) Prevalence of depression or depressive symptoms among outpatients stratified by age.
Figure 4
Figure 4
Forest plot of the eight studies that included control groups.
Figure 5
Figure 5
Funnel plots to test the publication bias of the 8 studies that included control groups. Each point represents a separate study on the indicated association. The points were distributed asymmetrically, indicating the existence of publication bias.

References

    1. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet 2016;388:1545–602. 10.1016/S0140-6736(16)31678-6 - DOI - PMC - PubMed
    1. World Health Organization. The World Health Report 2002: Reducing Risks, Promoting Healthy Life. 2002. - PubMed
    1. Kuo DC, Tran M, Shah AA, et al. . Depression and the suicidal patient. Emerg Med Clin North Am 2015;33:765–78. 10.1016/j.emc.2015.07.005 - DOI - PubMed
    1. Ismail Z, Elbayoumi H, Fischer CE, et al. . Prevalence of depression in patients with mild cognitive impairment: a systematic review and meta-analysis. JAMA Psychiatry 2017;74:58–67. 10.1001/jamapsychiatry.2016.3162 - DOI - PubMed
    1. Mitchell AJ, Chan M, Bhatti H, et al. . Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 2011;12:160–74. 10.1016/S1470-2045(11)70002-X - DOI - PubMed

LinkOut - more resources